Lineage Cell Therapeutics...

AMEX: LCTX · Real-Time Price · USD
0.97
0.02 (2.11%)
At close: Jun 23, 2025, 3:59 PM
0.99
2.37%
After-hours: Jun 23, 2025, 07:53 PM EDT
2.11%
Bid 0.95
Market Cap 220.73M
Revenue (ttm) 9.56M
Net Income (ttm) -16.21M
EPS (ttm) -0.07
PE Ratio (ttm) -13.81
Forward PE -18.3
Analyst Buy
Ask 1.03
Volume 7,849,013
Avg. Volume (20D) 1,503,132
Open 0.99
Previous Close 0.95
Day's Range 0.88 - 1.05
52-Week Range 0.37 - 1.15
Beta 1.52

About LCTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LCTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
7 months ago
-28.99%
Lineage Cell Therapeutics shares are trading lower... Unlock content with Pro Subscription
10 months ago
+1.8%
Lineage Cell Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.